Status:
COMPLETED
Agency in Dystonia
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Dystonia, Primary
Eligibility:
All Genders
15-65 years
Phase:
NA
Brief Summary
In this study, using computerized cognitive assessments combined with multi-modal neuroimaging approach investigators aim to address three specific questions on patients with cervical and myoclonus dy...
Detailed Description
This is a single-centre, two-group ( dystonia and control), case-control study using behavioural and novel multimodal neuroimaging techniques to address the study aims. The battery of the tasks will ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- diagnosis of isolated adult-onset cervical dystonia (CD) or myoclonus dystonia (MD);
- duration of disease of more than one year
- no botulinum toxin injection for at least three months before the study
- normal or corrected-to-normal vision.
- Exclusion Criteria
- any neurological history except for dystonia,
- history of dopamine antagonist treatment,
- secondary dystonia,
- dystonia in the upper limbs,
- inability to maintain gaze straight.
Exclusion
Key Trial Info
Start Date :
October 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2022
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT03351218
Start Date
October 23 2017
End Date
December 20 2022
Last Update
December 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre d'investigation Clinique
Paris, Île-de-France Region, France, 75013